So They Say

Reagan’s Non-Response to AIDS AIDS is the most serious threat to public health in decades. Historians will look back in astonishment at the Reagan Administration’s flaccid response during the first eight years of the epidemics has spread. They will ask how any President could fail to implement the most obvious public health measures, or tardily assign the making of national strategy to a quarreling commission with no recognizable expertise. They will wonder how his cabinet members

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

AIDS is the most serious threat to public health in decades. Historians will look back in astonishment at the Reagan Administration’s flaccid response during the first eight years of the epidemics has spread. They will ask how any President could fail to implement the most obvious public health measures, or tardily assign the making of national strategy to a quarreling commission with no recognizable expertise. They will wonder how his cabinet members could be torpid spectators of the virus’s spread, seeing it only as a pretext for impressing their own morals on others.

—Editorial: “The Reagan AIDS
Strategy in Ruins
The New York Times, Sec. 4,
p. 26, October 11, 1987

I’m rather bemused by the immense hope the new technology of genetic engineering is perceived to hold for solving most of the world’s problems.... I suggest there is an analogy here to the hope promulgated by the mechanical engineers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies